Grant: Discovery Grants Program - Individual
University of Toronto
$54,000.00
Cardiac tissue engineering and cell separation
EF 2010-11
Résumé
Chronic cardiovascular disease such as heart failure is increasing to epidemic levels, affecting 1 in 5 Canadians. The goal of this application is to enable the development of the alternative therapies for heart disease through tissue engineering. Adult cardiomyocytes (CM) have a limited ability to proliferate, thus stem cells must be used as their source. The ability to generate cardiovascular lineages from either embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs), provides an unprecedented opportunity to establish human in vitro models of cardiovascular disease as well as to develop replacement cardiac tissue for therapeutic applications. Over next 5 years, my research program will focus on enabling those goals by 1) Tissue engineering of cardiac patches based on stem cell derived CM and 2) Developing microfluidic separation methods for high-purity isolation of CM from heterogeneous populations. These two goals are interconnected as Project 2 can provide cells for Project 1. In Project 1, we hypothesize that modulating cell culture conditions, specifically the regime of electrical field stimulation of CM seeded into scaffolds with topographical guidance cues will enable us to develop a diseased vs. healthy myocardium in vitro. The healthy myocardium model can also be used for implantation. Mouse ESC will be the source of CM in initial studies, followed by human ESC and human iPSC. CM surface markers are not known, thus standard methods such as FACS cannot be implemented for isolation of living cells. In Project 2, we hypothesize that CMs will behave as paramagnetic particles during flow in a magnetic field gradient. The CM will be isolated from neonatal rat hearts and from differentiating ESC derived cardiovascular progenitors. The iron in myoglobin of CM will be transiently oxidized to the paramagnetic (Fe3+) form and the separation will be achieved in columns packed with magnetic beads (for 10^6-10^8 cell yield) or the microfluidic devices fitted with a ferromagnetic Nickel wire for separation of cells from small samples such as cardiac biopsies. Magnetic field gradient and fluid axial velocity will be investigated.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
326982-2010
Name nom
Radisic, Milica
Department département
Biomaterials and Biomedical Engineering, Inst. of (IBBME)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2010
Award amount
54000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
5
Application title
Cardiac tissue engineering and cell separation
Keyword
NSERC
Application summary
Chronic cardiovascular disease such as heart failure is increasing to epidemic levels, affecting 1 in 5 Canadians. The goal of this application is to enable the development of the alternative therapies for heart disease through tissue engineering. Adult cardiomyocytes (CM) have a limited ability to proliferate, thus stem cells must be used as their source. The ability to generate cardiovascular lineages from either embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs), provides an unprecedented opportunity to establish human in vitro models of cardiovascular disease as well as to develop replacement cardiac tissue for therapeutic applications. Over next 5 years, my research program will focus on enabling those goals by 1) Tissue engineering of cardiac patches based on stem cell derived CM and 2) Developing microfluidic separation methods for high-purity isolation of CM from heterogeneous populations. These two goals are interconnected as Project 2 can provide cells for Project 1. In Project 1, we hypothesize that modulating cell culture conditions, specifically the regime of electrical field stimulation of CM seeded into scaffolds with topographical guidance cues will enable us to develop a diseased vs. healthy myocardium in vitro. The healthy myocardium model can also be used for implantation. Mouse ESC will be the source of CM in initial studies, followed by human ESC and human iPSC. CM surface markers are not known, thus standard methods such as FACS cannot be implemented for isolation of living cells. In Project 2, we hypothesize that CMs will behave as paramagnetic particles during flow in a magnetic field gradient. The CM will be isolated from neonatal rat hearts and from differentiating ESC derived cardiovascular progenitors. The iron in myoglobin of CM will be transiently oxidized to the paramagnetic (Fe3+) form and the separation will be achieved in columns packed with magnetic beads (for 10^6-10^8 cell yield) or the microfluidic devices fitted with a ferromagnetic Nickel wire for separation of cells from small samples such as cardiac biopsies. Magnetic field gradient and fluid axial velocity will be investigated.